Evaluating transcatheter arterial embolisation for improvement of pain in osteoarthritis (OA) of the knee
- Conditions
- Knee osteoarthritisMusculoskeletal - Osteoarthritis
- Registration Number
- ACTRN12616001184460
- Lead Sponsor
- Barwon Medical Imaging
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 59
1. People aged 18 to 75 years
2. Grade 2 knee OA (obtained via baseline imaging (X-Ray) as per Kellgren-Lawrence Grading Scale)
3. Moderate to severe knee pain
4. Knee pain for at least six months
5. Pain resistant to conservative treatment
a. Conservative treatment includes medication (e.g. paracetamol, anti-inflammatories), or intra-articular injections, or physiotherapy or exercise, or weight loss.
6. Participants must be willing, able and mentally competent to provide informed consent (able to read and understand the Patient Information and Consent Form)
1. Local infection
2. Active malignancy
3. Rheumatoid Arthritis or Seronegative Arthropathies
4. Prior Ipsilateral Knee Surgery
5. Kellgren-Lawrence Grade 3 and above
6. Current pregnancy
a. If participant is unsure of their current pregnancy status clarification from their GP including arranging a pregnancy test and following up the result can be obtained
7. Known history of allergy to contrast media
8. Weight greater than 200kg
9. Barwon Medical Imaging Protocols:
a.Platelets < 100 x 109/L
b. INR > 1.5
c. Estimated GFR < 30ml/min.1.73m2
10. Approved for knee joint replacement surgery
11. Moderate to severe pain in other lower limb joints
12. History of allergy to carbapenem (e.g. imipenem, ertapenem or meropenem), or having an immediate or severe hypersensitivity reaction to a penicillin or cephalosporin antibiotic
13. History of seizures or using valproate
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method